USPTO serial 99663572
DR. HERO
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROOKSHIRE, DAVID AARON
- Law office
- TMO LAW OFFICE 137
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with DR. HERO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Aurora, CO, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Albumin dietary supplements; Baby food; Calcium supplements; Cod liver oil; Dietary and nutritional supplements; Food supplements; Herbal supplements; Mineral supplements; Probiotic supplements; Protein supplements; Vitamin and mineral supplements; Yeast dietary supplements; Zinc dietary supplements; Powdered milk for babies; Dietary supplemental drinks; Dietary supplements for pets; Gargles; Mouth cavity cleansers | ACTIVE | Jan 22, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 7, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 7, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2026 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jun 19, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 18, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 21, 2026 | NWAP | NEW APPLICATION ENTERED | — |